This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Cannabis: Difference between revisions
>Debt00 m Added zaza, kush to also known as section where it lists subsitute names for weed, and changed all the names in the titles of the citations to regular capitalization, added THC reference |
>MegurineLuka m tiny typo |
||
| (6 intermediate revisions by 5 users not shown) | |||
| Line 196: | Line 196: | ||
*Cannabinoid ratios: On average, ''Cannabis indica'' has higher levels of [[Tetrahydrocannabinol|THC]] compared to [[Cannabidiol|CBD]], whereas ''Cannabis sativa'' has lower levels of THC to CBD.<ref name="Hillig">{{cite journal |author1=Karl W. Hillig |author2=Paul G. Mahlberg |year=2004 |title=A chemotaxonomic analysis of cannabinoid variation in ''Cannabis'' (Cannabaceae) |journal=[[American Journal of Botany]] |volume=91 |issue=6 |pages=966–975 |pmid=21653452 |doi=10.3732/ajb.91.6.966|doi-access=free }}</ref> However, huge variability exists within either species. A 2015 study shows the average THC content of the most popular herbal cannabis products in the Netherlands has decreased slightly since 2005.<ref>{{cite journal |vauthors=Niesink RJ, Rigter S, Koeter MW, Brunt TM |title=Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15 |journal=Addiction |volume=110 |issue=12 |pages=1941–50 |year=2015 |doi=10.1111/add.13082 |pmid=26234170}}</ref> | *Cannabinoid ratios: On average, ''Cannabis indica'' has higher levels of [[Tetrahydrocannabinol|THC]] compared to [[Cannabidiol|CBD]], whereas ''Cannabis sativa'' has lower levels of THC to CBD.<ref name="Hillig">{{cite journal |author1=Karl W. Hillig |author2=Paul G. Mahlberg |year=2004 |title=A chemotaxonomic analysis of cannabinoid variation in ''Cannabis'' (Cannabaceae) |journal=[[American Journal of Botany]] |volume=91 |issue=6 |pages=966–975 |pmid=21653452 |doi=10.3732/ajb.91.6.966|doi-access=free }}</ref> However, huge variability exists within either species. A 2015 study shows the average THC content of the most popular herbal cannabis products in the Netherlands has decreased slightly since 2005.<ref>{{cite journal |vauthors=Niesink RJ, Rigter S, Koeter MW, Brunt TM |title=Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15 |journal=Addiction |volume=110 |issue=12 |pages=1941–50 |year=2015 |doi=10.1111/add.13082 |pmid=26234170}}</ref> | ||
*Terpene ratios: Sativa ancestry is associated with farnesene and | *Terpene ratios: Sativa ancestry is associated with farnesene and bergamotene, while Indica ancestry is associated with myrcene, elemene, and sesquiterpene alcohols. | ||
=====Criticism===== | =====Criticism===== | ||
| Line 279: | Line 279: | ||
===Trauma=== | ===Trauma=== | ||
[https://en.wikipedia.org/wiki/ | [https://en.wikipedia.org/wiki/Cannabis_use_and_trauma Cannabis use and trauma] are linked, with trauma playing a role in encouraging both the use and potential misuse of cannabis.<ref>{{cite journal | vauthors = Hyman SM, Sinha R | title = Stress-related factors in cannabis use and misuse: implications for prevention and treatment | journal = Journal of Substance Abuse Treatment | volume = 36 | issue = 4 | pages = 400–13 | date = June 2009 | pmid = 19004601 | doi = 10.1016/j.jsat.2008.08.005 | pmc = 2696937 }}</ref> Conversely, cannabis use has been associated with the intensity of trauma and PTSD symptoms.<ref name=":0">{{cite journal | vauthors = Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ | title = Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users | journal = Journal of Traumatic Stress | volume = 20 | issue = 4 | pages = 577–86 | date = August 2007 | pmid = 17721963 | doi = 10.1002/jts.20243 }}</ref><ref>{{cite journal | vauthors = Kevorkian S, Bonn-Miller MO, Belendiuk K, Carney DM, Roberson-Nay R, Berenz EC | title = Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample | journal = Psychology of Addictive Behaviors | volume = 29 | issue = 3 | pages = 633–8 | date = September 2015 | pmid = 26415060 | doi = 10.1037/adb0000110 | pmc = 4699174 }}</ref> While evidence of efficacious use of cannabis is growing in novelty, it is not currently recommended.<ref>{{cite journal | vauthors = Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L | display-authors = 6 | title = Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis | journal = The Lancet. Psychiatry | volume = 6 | issue = 12 | pages = 995–1010 | date = December 2019 | pmid = 31672337 | doi = 10.1016/s2215-0366(19)30401-8 | pmc = 6949116 }}</ref><ref>{{cite journal | vauthors = Dagan Y, Yager J | title = Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms | journal = The Journal of Nervous and Mental Disease | volume = 208 | issue = 8 | pages = 619–627 | date = August 2020 | pmid = 32433200 | doi = 10.1097/nmd.0000000000001172 | s2cid = 218766009 }}</ref> | ||
===Lethal dosage=== | ===Lethal dosage=== | ||